Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shechter

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2009
Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditionsK Sasson, Y Marcus, V Lev-Goldman, et al.
Pediatric Nephrology (Berlin, Germany)|February 24, 2001
Plasmapheresis in a very young infant with atypical hemolytic uremic syndromeD Magen, A Oliven, Y Shechter, et al.
The Journal of Biological Chemistry|September 3, 1999
L-Glutamic acid gamma-monohydroxamate. A potentiator of vanadium-evoked glucose metabolism in vitro and in vivoI Goldwaser, J Li, E Gershonov, et al.
Vox Sanguinis|January 1, 1991
Neonatal alloimmune thrombocytopenia due to anti-Brb (HPA-5a). Report of three cases in two familiesV Kiefel, Y Shechter, D Atias, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 23, 2008
Reversible pegylation of insulin facilitates its prolonged action in vivoY Shechter, M Mironchik, S Rubinraut, et al.
Molecular and Cellular Biochemistry|December 6, 1995
Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatasesY Shechter, J Li, J Meyerovitch, et al.
Immunology|October 10, 1998
Human/BALB radiation chimera engrafted with splenocytes from patients with idiopathic thrombocytopenic purpura produce human platelet antibodiesB Dekel, H Marcus, B Shenkman, et al.
American Journal of Medical Genetics|October 1, 1992
Rambam-Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotypeM Frydman, A Etzioni, T Eidlitz-Markus, et al.
Nature|June 30, 1983
Autoantibodies to the insulin receptor in juvenile onset insulin-dependent diabetesR Maron, D Elias, B M de Jongh, et al.
British Journal of Haematology|September 13, 2001
Cells from chronic myelogenous leukaemia patients at presentation exhibit multidrug resistance not mediated by either MDR1 or MRP1A Carter, E J Dann, T Katz, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2009
Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditionsK Sasson, Y Marcus, V Lev-Goldman, et al.
Pediatric Nephrology (Berlin, Germany)|February 24, 2001
Plasmapheresis in a very young infant with atypical hemolytic uremic syndromeD Magen, A Oliven, Y Shechter, et al.
The Journal of Biological Chemistry|September 3, 1999
L-Glutamic acid gamma-monohydroxamate. A potentiator of vanadium-evoked glucose metabolism in vitro and in vivoI Goldwaser, J Li, E Gershonov, et al.
Vox Sanguinis|January 1, 1991
Neonatal alloimmune thrombocytopenia due to anti-Brb (HPA-5a). Report of three cases in two familiesV Kiefel, Y Shechter, D Atias, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 23, 2008
Reversible pegylation of insulin facilitates its prolonged action in vivoY Shechter, M Mironchik, S Rubinraut, et al.
Molecular and Cellular Biochemistry|December 6, 1995
Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatasesY Shechter, J Li, J Meyerovitch, et al.
Immunology|October 10, 1998
Human/BALB radiation chimera engrafted with splenocytes from patients with idiopathic thrombocytopenic purpura produce human platelet antibodiesB Dekel, H Marcus, B Shenkman, et al.
American Journal of Medical Genetics|October 1, 1992
Rambam-Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotypeM Frydman, A Etzioni, T Eidlitz-Markus, et al.
Nature|June 30, 1983
Autoantibodies to the insulin receptor in juvenile onset insulin-dependent diabetesR Maron, D Elias, B M de Jongh, et al.
British Journal of Haematology|September 13, 2001
Cells from chronic myelogenous leukaemia patients at presentation exhibit multidrug resistance not mediated by either MDR1 or MRP1A Carter, E J Dann, T Katz, et al.
Pageof 14